These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34442871)

  • 1. MDR and Pre-XDR Clinical
    Fursov MV; Shitikov EA; Lagutkin DA; Fursova AD; Ganina EA; Kombarova TI; Grishenko NS; Rudnitskaya TI; Bespiatykh DA; Kolupaeva NV; Firstova VV; Domotenko LV; Panova AE; Vinokurov AS; Gushchin VA; Tkachuk AP; Vasilyeva IA; Potapov VD; Dyatlov IA
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442871
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotyping, Assessment of Virulence and Antibacterial Resistance of the Rostov Strain of
    Fursov MV; Shitikov EA; Bespyatykh JA; Bogun AG; Kislichkina AA; Kombarova TI; Rudnitskaya TI; Grishenko NS; Ganina EA; Domotenko LV; Fursova NK; Potapov VD; Dyatlov IA
    Pathogens; 2020 Apr; 9(5):. PubMed ID: 32365818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Population structure analysis of Mycobacterium tuberculosis Beijing family in Japan].
    Iwamoto T
    Kekkaku; 2009 Dec; 84(12):755-9. PubMed ID: 20077859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine model.
    Smith KL; Saini D; Bardarov S; Larsen M; Frothingham R; Gandhi NR; Jacobs WR; Sturm AW; Lee S
    PLoS One; 2014; 9(4):e94953. PubMed ID: 24733050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pathobiological diversity of Mycobacterium tuberculosis on clinical features and lethal outcome of tuberculosis.
    Mokrousov I; Pasechnik O; Vyazovaya A; Yarusova I; Gerasimova A; Blokh A; Zhuravlev V
    BMC Microbiol; 2022 Feb; 22(1):50. PubMed ID: 35135478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely lethal and hypervirulent
    Vinogradova T; Dogonadze M; Zabolotnykh N; Badleeva M; Yarusova I; Vyazovaya A; Gerasimova A; Zhdanova S; Vitovskaya M; Solovieva N; Pasechnik O; Ogarkov O; Mokrousov I
    Emerg Microbes Infect; 2021 Dec; 10(1):1691-1701. PubMed ID: 34380361
    [No Abstract]   [Full Text] [Related]  

  • 8. Insight into Population Structure and Drug Resistance of Pediatric Tuberculosis Strains from China and Russia Gained through Whole-Genome Sequencing.
    Zhdanova S; Jiao WW; Sinkov V; Khromova P; Solovieva N; Mushkin A; Mokrousov I; Belopolskaya O; Masharsky A; Vyazovaya A; Rychkova L; Kolesnikova L; Zhuravlev V; Shen AD; Ogarkov O
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome analysis of an MDR Beijing/W strain of Mycobacterium tuberculosis with large genomic deletions associated with resistance to isoniazid.
    Zhang Q; Wan B; Zhou A; Ni J; Xu Z; Li S; Tao J; Yao Y
    Gene; 2016 May; 582(2):128-36. PubMed ID: 26854371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Diversity and Primary Drug Resistance of
    Vyazovaya A; Gerasimova A; Mudarisova R; Terentieva D; Solovieva N; Zhuravlev V; Mokrousov I
    Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical isolates of
    Liang C; Li X; Li Q; Zhang X; Ren W; Yao C; Pang Y; Liu Y; Li C; Tang S
    J Med Microbiol; 2022 Dec; 71(11):. PubMed ID: 36748527
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage.
    Ribeiro SC; Gomes LL; Amaral EP; Andrade MR; Almeida FM; Rezende AL; Lanes VR; Carvalho EC; Suffys PN; Mokrousov I; Lasunskaia EB
    J Clin Microbiol; 2014 Jul; 52(7):2615-24. PubMed ID: 24829250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Merker M; Nikolaevskaya E; Kohl TA; Molina-Moya B; Pavlovska O; Brännberg P; Dudnyk A; Stokich V; Barilar I; Marynova I; Filipova T; Prat C; Sjöstedt A; Dominguez J; Rzhepishevska O; Niemann S
    Emerg Infect Dis; 2020 Mar; 26(3):481-490. PubMed ID: 32091369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority country.
    Mokrousov I; Vyazovaya A; Levina K; Gerasimova A; Zhuravlev V; Viiklepp P; Kütt M
    Transbound Emerg Dis; 2021 Mar; 68(2):896-906. PubMed ID: 32737943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
    Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
    Front Immunol; 2021; 12():796677. PubMed ID: 35003120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early ancient sublineages of Mycobacterium tuberculosis Beijing genotype: unexpected clues from phylogenomics of the pathogen and human history.
    Mokrousov I; Vyazovaya A; Pasechnik O; Gerasimova A; Dymova M; Chernyaeva E; Tatarintseva M; Stasenko V
    Clin Microbiol Infect; 2019 Aug; 25(8):1039.e1-1039.e6. PubMed ID: 30528901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
    Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
    BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.
    de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; Aarnoutse RE; Boeree MJ; den Bakker MA; van Soolingen D; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4937-44. PubMed ID: 22802244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteogenomic analysis of Mycobacterium tuberculosis Beijing B0/W148 cluster strains.
    Bespyatykh J; Smolyakov A; Guliaev A; Shitikov E; Arapidi G; Butenko I; Dogonadze M; Manicheva O; Ilina E; Zgoda V; Govorun V
    J Proteomics; 2019 Feb; 192():18-26. PubMed ID: 30009986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.